Goldman, Sachs & Co. Wertpapier GmbH Share Price

Certificat

DE000GX2CUW8

Delayed Deutsche Boerse AG 12:55:36 18/07/2024 pm IST
91.83 CHF +1.09% Intraday chart for Goldman, Sachs & Co. Wertpapier GmbH
Current month+7.31%
1 month+10.10%
Date Price Change
18/24/18 91.83 +1.09%
17/24/17 90.84 +5.08%
16/24/16 86.45 +0.57%
15/24/15 85.96 +0.66%
12/24/12 85.4 +0.67%

Delayed Quote Deutsche Boerse AG

Last update July 18, 2024 at 12:55 pm IST

More quotes

Static data

Product typesonstige Zertifikate
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Goldman Sachs
WKN GX2CUW
ISINDE000GX2CUW8
Date issued 21/10/2021
Strike 307.7 CHF
Maturity 21/10/2024 (96 Days)
Parity 0.31 : 1
Emission price 100 CHF
Emission volume N/A
Settlement Beides
Currency CHF

Technical Indicators

Highest since issue 100.1 CHF
Lowest since issue 71.77 CHF
Spread 10 CHF
Spread %1.08%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
274 CHF
Average target price
274 CHF
Spread / Average Target
0.00%
Consensus